1-9 of 9
Keywords: tumour
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (2005) 109 (3): 227–241.
Published: 24 August 2005
..., VEGF-A and its receptor are involved in carcinogenesis, invasion and distant metastasis as well as tumour angiogenesis. VEGF-A also has a neuroprotective effect on hypoxic motor neurons, and is a modifier of ALS (amyotrophic lateral sclerosis). Recent progress in the molecular and biological...
Clin Sci (Lond) (2005) 108 (5): 369–383.
Published: 22 April 2005
... the basic features of proteomic technologies, including the basics of MS, and we consider the main current applications and challenges of proteomics in cancer research, including (i) protein expression profiling of tumours, tumour fluids and tumour cells; (ii) protein microarrays; (iii) mapping of cancer...
Clin Sci (Lond) (2002) 102 (2): 143–150.
Published: 03 January 2002
... that of the extranuclear bile acid pool. Moreover, they indicate that, during hepatocarcinogenesis, the composition of the nuclear pool undergoes important alterations. The Biochemical Society and the Medical Research Society © 2002 2002 allo-cholic acid cancer hepatocyte neoplasia tumour ursodeoxycholic acid...
Clin Sci (Lond) (2001) 100 (5): 499–508.
Published: 27 March 2001
...-mail jjgmarin@gugu.usal.es ). 17 7 2000 1 12 2000 12 1 2001 The Biochemical Society and the Medical Research Society © 2001 2001 allo-cholic acid cancer differentiation marker neoplasia tumour unsaturated bile acids ...
Clin Sci (Lond) (1998) 95 (3): 385–388.
Published: 01 September 1998
... not have cyclo-oxygenase nor RNA for synthesis of such enzymes are affected by sulindac. Therefore the presumptive effect is probably not correct. 2. It has also been found that sulindac stimulates apoptosis. It is herein postulated that in tumour cells such effects may be due to interaction of the anionic...
Clin Sci (Lond) (1994) 86 (3): 339–345.
Published: 01 March 1994
...) and tumour tissue (43.9 ± 10.3%/day versus 22.6 ± 5.6%/day in saline control). 4. Pre-operative nutrition enriched with branched-chain amino acids was less effective than conventional intravenous nutrition in stimulating protein synthesis in both muscle and tumour. The rates of protein synthesis were 2.12...
Clin Sci (Lond) (1981) 61 (s7): 299s–301s.
Published: 01 December 1981
... dialysis. This neutral activation was completely abolished by a serine proteinase inhibitor. 3. A large fraction of the renin in this tumour is inactive. In comparison with other pro-hormones produced in tumours the findings support strongly the proposition that renin passes through a proenzyme step...
Clin Sci Mol Med (1976) 51 (s3): 117s–120s.
Published: 01 December 1976
... culture tissue iso-renin tumour © 1976 The Biochemical Society and the Medical Research Society 1976 Clinical Science and Molecular Medicine (1976) 51, 117s-120s. REVIEW Tissue iso-renins D. GANTEN, J. S. HUTCHINSON, H. HAEBARA, P. SCHELLING, Department of Pharmacology, University of Heidelberg...